Efficacy and Safety of Losartan in Children With Ig A Nephropathy
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that using Losartan would help decrease proteinuria in
controlling proteinuria in children with immunoglobulin A nephropathy.